400 Preclinical Studies Support Combined Inhibition of BET Family Proteins and Histone Deacetylases as Epigenetic Therapy for Cutaneous T-Cell Lymphoma

Journal of Investigative Dermatology - United Kingdom
doi 10.1016/j.jid.2018.03.407
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Inhibition of Histone Deacetylases in Cancer Therapy: Lessons From Leukaemia

British Journal of Cancer
Cancer ResearchOncology
2016English

423 Gentian Violet Induces Pro-Apoptotic and Anti-Proliferative Effects in Cutaneous T-Cell Lymphoma (CTCL): Preclinical Studies

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2018English

Innovative Strategies for Selective Inhibition of Histone Deacetylases

Cell Chemical Biology
Molecular MedicineMolecular BiologyPharmacologyBiochemistryClinical BiochemistryDrug Discovery
2016English

Precision Epigenetic Therapy for B-Cell Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Ten-Year Experience of Bexarotene Therapy for Cutaneous T-Cell Lymphoma in Finland

Acta Dermato-Venereologica
DermatologyMedicine
2012English

LB1550 Skin Commensals as Instigators of Cutaneous T Cell Lymphoma

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2018English

Single-Fraction Radiation Therapy Provides Highly Effective Palliation for Cutaneous T-Cell Lymphoma

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

Cutaneous T Cell Lymphoma (Mycosis Fungoides)

JMS SKIMS
2010English

687 BET Inhibitor Suppressed Tumor Growth and Associated TME Inflammation in Mouse Models of Cutaneous T Cell Lymphoma

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy